AUG 04, 2021 10:05 PM PDT

Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial

WRITTEN BY: Angela Dowden

A phase II trial is being planned to test the cannabis-derived drug Sativex, in patients with aggressive brain tumors.

The trial is set to take place in 15 hospitals in the UK, and will be coordinated by the Cancer Research UK Clinical Trials Unit and researchers at the University of Leeds, in northern England . 

The Brain Tumour Charity, also UK based, is fund-raising to cover the trial’s estimated costs, which are £450,00 ($627,000).

Sativex, made by GW Pharma, is a cannabis drug that comes in the form of an oral spray, containing the cannabinoids THC and CBD. The intention is to use Sativex in conjunction with chemotherapy in patients who have recurrence of a glioblastoma brain tumor following initial treatment. 

According to chief investigator Dr Susan Short, glioblastomas that are initially successfully treated nearly always regrow within a year, and there are few treatment options once this happens. However glioblastoma brain tumours have been shown to have receptors to cannabinoids on their cell surfaces, which has intrigued researchers and offered some hope that cannabis-based drugs may offer a more positive prognosis for brain tumor patients.

“Laboratory studies on glioblastoma cells have shown these drugs may slow tumour growth and work particularly well when used with temozolomide,” Dr Short explained.

A previous Phase I study of Sativex in 27 patients found that more patients were alive after one year on the drug versus placebo arm, but the trial was too small to show any significant difference in survival.

By comparison the new Phase II trial will involve ten times as many patients. It will begin early 2022, subject to the funding target being met.

Sources: University of Leeds, BBC, Pharma Times

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
AUG 25, 2021
Genetics & Genomics
A Possible Treatment Strategy for Familial Alzheimer's is ID'ed
AUG 25, 2021
A Possible Treatment Strategy for Familial Alzheimer's is ID'ed
Some cases of Alzheimers disease (AD) are known as Familial AD because they are due to genetic mutations. So far, mutati ...
AUG 24, 2021
Plants & Animals
Flanged male orangutans experience more severe early life stress
AUG 24, 2021
Flanged male orangutans experience more severe early life stress
Linear enamel hypoplasia, or LEH, occurs when tooth enamel fails to develop correctly during growth. When the enamel sto ...
AUG 30, 2021
Health & Medicine
For the love of java: Researchers find association, not causation, between excessive coffee consumption, brain size, and dementia
AUG 30, 2021
For the love of java: Researchers find association, not causation, between excessive coffee consumption, brain size, and dementia
Researchers find association, not causation, between excessive coffee consumption, brain size, and dementia
SEP 08, 2021
Technology
Vaping Devices With Nicotine Increase the Frequency of Blood Clots
SEP 08, 2021
Vaping Devices With Nicotine Increase the Frequency of Blood Clots
The safety of e-cigarettes, or vaping devices, has been the topic of fierce debate recently. Some advocates suggest that ...
SEP 13, 2021
Genetics & Genomics
Moderna is Developing mRNA Vaccines to Rescue Different Protein Defects
SEP 13, 2021
Moderna is Developing mRNA Vaccines to Rescue Different Protein Defects
A genome contains instructions for making genes, and when an organism needs to produce proteins, it transcribes a gene s ...
SEP 17, 2021
Earth & The Environment
City Solutions - Green Rooftops in Urban Spaces
SEP 17, 2021
City Solutions - Green Rooftops in Urban Spaces
Most of the world’s population lives in cities. Population growth is expected to continue to be focused in urban a ...
Loading Comments...